Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This randomized study aims to compare the effectiveness of individualized dietary recommendations (Gustabor group) with the current standard of care -general recommendations (Control group). Participants will undergo an objective assessment of taste disorders using taste strips and questionnaires. Based on the results, the Gustabor group will receive both general and specific dietary suggestions. These will be accomapnied by AI-generated recipe suggestions tailored to specific taste disorders (e.g., more cold foods in cases of metallic taste). The control group will receive the current standard: a flyer containing general dietary advice for oncology patients previously shown to be beneficial for managing taste alterations. The primary endpoint is the PG-SGA score within 12 weeks of inclusion.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Diagnoza jednego z następujących raków: szpiczak plazmocytowy, czerniak, rak narządów moczowo-płciowych lub rak przewodu pokarmowego
- •Możliwość jedzenia naturalnie przez usta
- •Zaburzenia smaku związane z leczeniem nowotworu
- •Możliwość uczestniczenia w interwencji dietetycznej, w tym korzystania z portalu internetowego i przygotowywania potraw
✗ Disqualifies
- •Ciąża
- •Zaburzenia smaku z innych przyczyn niż leczenie raka
- •Pobytu w zakładzie opieki długoterminowej
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 20, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (6)
Universitätsklinikum Augsburg
Augsburg, Germany
Universitätsklinikum Erlangen
Erlangen, Germany
LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center
München, Germany
Klinikum der Technischen Universität München (TUM Klinikum)
München, Germany
Universitätsklinikum Regensburg
Regensburg, Germany
Universitätsklinikum Würzburg
Würzburg, Germany
Trial contact
Prof. Dr. med. Alexander Hann
Dr. med. Anna Fleischer
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.